Facebook Twitter LinkedIn Google Plus RSS

Advaxis closes $26.5M public offering

Advaxis Inc., a Princeton biotech specializing in drugs treating cancer and infectious diseases, announced Tuesday the closing of its recent public offering.

Continue Reading »»

You May Have Missed...

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy